The biotechnology company posted revenue of $11.5 million in the period, also topping Street forecasts. Eight analysts surveyed by Zacks expected ...
News
- Bluebird: 3Q Earnings Snapshot
- The Coffee Lover's Guide to San Antonio
In the last decade, Local Coffee has made its mark on San Antonio and ... who still works full-time at the Texas Biomedical Research Institute, started ...
- AP FACT CHECK: Ad on Tina Smith's investments is misleading
Johnson & Johnson is a massive company that recorded $76.5 billion in sales last year from its three divisions: biotech drugs, medical devices and ...
- Apple and Kraft Heinz drop while Starbucks and Symantec rise
Pacific Biosciences of California Inc., up $3.05 to $7.56. The genetic analysis technology company agreed to be bought by genetic testing tools maker ...
- Initial public offerings scheduled to debut next week
Business: Phase 3 biotech developing small molecule therapies for Alzheimer's disease. CNFinance Holdings - 6.5 million shares, priced $7.50-$8.50 ...